<DOC>
	<DOC>NCT00092599</DOC>
	<brief_summary>This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication.</brief_summary>
	<brief_title>Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)</brief_title>
	<detailed_description>The duration of treatment is 10 weeks.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patients with elevated cholesterol and coronary heart disease Patients who do not meet specific cholesterol levels as required by the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Elevated Cholesterol</keyword>
</DOC>